| 3α-HSD | 3α-hydroxysteroid dehydrogenase |
| 3β-HSD | 3β-hydroxysteroid dehydrogenase |
| 5α-DHPROG | 5α-dihydroprogesterone |
| 3α,5α-THPROG | 3α,5α-tetrahydroprogesterone (allopregnanolone) |
| 6-OHDA | 6-hydroxydopamine |
| AD | Alzheimer’s disease |
| BBB | Blood brain barrier |
| CNS | Central nervous system |
| CSF | Cerebrospinal fluid |
| EAE | Experimental autoimmune encephalomyelitis |
| GABA | γ-aminobutyric acid |
| Il-18 | Interferon-gamma inducing factor 18 |
| MCAO/R | Middle cerebral artery occlusion/reperfusion |
| mPR | Membrane progesterone receptors |
| MS | Multiple sclerosis |
| NLRP3 | NOD-like receptor pyrin domain containing 3 |
| NP-C | Niemann–Pick type C |
| P450scc | Cholesterol side-chain cleavage |
| PD | Parkinson’s disease |
| PGRMC1 | Membrane-associated progesterone receptor membrane component 1 |
| PR | Progesterone receptors |
| PROG | Progesterone |
| TBI | Traumatic brain injury |